Researchers identified three obesity subtypes in new research. In one subtype, individuals have low GLP-1 and rapid gastric ...

The Council today set its position on the remaining part of the ‘Omnibus X’ simplification package. The package aims to reduce unnecessary administrative costs and burdens, while maintaining the EU’s ...

Eli Lilly and Company (NYSE: LLY), the maker of Foundayo (orforglipron), today announced results from a new analysis showing ...

Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced detailed results from TRIUMPH-2, a Phase 3 trial evaluating the efficacy and safety ...

Many healthcare professionals do not attribute symptoms such as fatigue, mood changes or sleep disruptions to menopause, leading to a missed opportunity for proper treatment in midlife women, ...